13F Portfolios

Davern Capital Partners, LP: BIONTECH SE (BNTX): Quarterly 13F Position History

As of Q1 2026, Davern Capital Partners, LP reported 305,055 shares of BIONTECH SE (BNTX), worth $27.1M and representing 7.4% of its 13F equity book. Quarter-over-quarter share count change: 66,161 (-17.8%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.

Recent initiation: Davern Capital Partners, LP first reported BNTX on the Q4 2025 filing — fewer than three quarters of history are available.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 305,055 66,161 -17.8% $27.1M 7.4% $88.9
Q4 2025 371,216 $35.3M 11.4% $95.2

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Davern Capital Partners, LP first disclose a BNTX position in 13F-HR filings?

Davern Capital Partners, LP first reported BIONTECH SE (BNTX) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.

What was Davern Capital Partners, LP's most recent quarter-over-quarter share-count change in BNTX?

Between Q4 2025 and Q1 2026, Davern Capital Partners, LP reduced its BNTX position by 66,161 shares (-17.8%), leaving 305,055 shares at a market value of $27.1M.

Does the implied price-per-share represent Davern Capital Partners, LP's cost basis in BNTX?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.